临床前影像市场规模、份额和成长分析（按组件、模式、应用和地区划分）—2025-2032年产业预测

全球临床前影像市场规模预计在 2023 年达到 36 亿美元，从 2024 年的 37.7 亿美元成长到 2032 年的 54.9 亿美元，在预测期（2025-2032 年）内复合年增长率为 4.8%。

受药物研发、分子生物学和转化医学领域对先进研究仪器的需求不断增长的推动，临床前成像市场正经历强劲成长。该领域对于评估新药候选药物的疗效和安全性、了解疾病进展以及支持个人化医疗的发展至关重要。包括癌症和神经系统疾病在内的慢性疾病日益普遍，使得利用精准、非侵入性的影像技术分析动物模型中的疾病机制变得特别重要。高解析度磁振造影（MRI）、正子断层扫描（PET）、电脑断层扫描（CT）和多模态影像系统等技术的进步，正在提升我们即时观察细胞和分子层面疾病的能力。此外，人工智慧和机器学习在影像分析中的应用，也得益于该领域投资和合作的不断增长，从而提高了分析的准确性和效率。

全球临床前影像市场驱动因素

慢性疾病（包括癌症和神经系统疾病）的日益普遍，推动了人们对注重准确性和非侵入性的创新临床前成像技术的兴趣。这种需求的成长在製药和生物製药公司中尤其明显，这些公司正在利用这些先进的影像工具来评估药物疗效、追踪疾病进展并优化治疗策略。此外，对快速、全面的药物研发流程的需求不断增长，也促使人们对高解析度和多模态成像技术进行大量投资，进一步推动了全球临床前影像市场的成长，因为相关人员在寻求改善研究成果和治疗方案。

限制全球临床前影像市场的因素

全球临床前影像市场面临部署和维护成像系统高成本的严峻挑战。这种经济负担尤其对开发中国家的小型实验室、Start-Ups和研究机构构成障碍。高解析度磁振造影（MRI）、正子断层扫描/电脑断层扫描（PET/CT）和混合系统等先进影像技术不仅需要大量的初始投资，还需要持续投入资金用于系统校准、软体升级、维护和耗材。此外，聘用和培训操作这些先进系统的专业人员也增加了营运成本，并对追求尖端研究能力构成重大挑战。

全球临床前影像市场趋势

全球临床前影像市场正呈现出一个显着的趋势，其驱动力是人工智慧 (AI) 和机器学习 (ML) 技术的日益普及。这些先进工具透过实现自动化影像分析、精确的组织分割和更精准的生物标记识别，正在革新诊断影像领域。随着研究人员积极采用 AI 和 ML，他们受益于更少的人工干预和更高的准确性，从而能够从复杂的影像数据中获得更深入的洞察。这一趋势不仅提高了临床前试验的整体效率，也加速了关键发现的进程，推动了生物医学研究和药物开发的创新与进步。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

临床前影像市场规模（按组件划分）及复合年增长率（2025-2032 年）

• 市场概览
• 硬体系统
• 软体和服务

依影像方式分類的临床前影像市场规模及复合年增长率（2025-2032 年）

• 市场概览
• 磁振造影（MRI）
• 正子断层扫描（PET）
• 电脑断层扫描（CT）
• 光学成像
• 超音波成像
• 单光子发射电脑断层扫描（SPECT）
• 多模态成像

按应用领域分類的临床前影像市场规模及复合年增长率（2025-2032 年）

• 市场概览
• 药物发现与开发
• 疾病研究
• 转换医学
• 毒理学研究

临床前影像市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2024 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2024 年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2022-2024年营收年比比较

主要企业简介

• Bruker Corporation（USA）
• Revvity, Inc.（USA）
• FUJIFILM VisualSonics Inc.（Canada）
• Mediso Medical Imaging Systems Ltd.（Hungary）
• MR Solutions（UK）
• Aspect Imaging Limited（USA）
• TriFoil Imaging（USA）
• MILabs BV（Netherlands）
• Siemens Healthineers AG（Germany）
• General Electric（GE）HealthCare Technologies Inc.（USA）
• Cubresa Inc.（Canada）
• Berthold Technologies GmbH & Co. KG（Germany）
• Miltenyi Biotec GmbH（Germany）
• Li-Cor Biosciences（USA）
• Sofie（USA）
• Advanced Molecular Vision（UK）
• Vieworks Co., Ltd.（South Korea）
• Kub Technologies（USA）
• Medikors Inc.（South Korea）
• SCANCO Medical AG（Switzerland）

结论与建议

Global Preclinical Imaging Market size was valued at USD 3.6 billion in 2023 and is poised to grow from USD 3.77 billion in 2024 to USD 5.49 billion by 2032, growing at a CAGR of 4.8% during the forecast period (2025-2032).

The preclinical imaging market is witnessing robust expansion, driven by heightened demand for sophisticated research instruments utilized in drug discovery, molecular biology, and translational medicine. This segment is essential for assessing the efficacy and safety of novel drug candidates, understanding disease progression, and aiding in the creation of personalized therapies. The escalating prevalence of chronic ailments, including cancer and neurological disorders, necessitates precise, non-invasive imaging methods for analyzing disease mechanisms in animal models. Advances in technology, such as high-resolution MRI, PET, CT, and multimodal imaging systems, enhance researchers' capabilities for real-time visualization at cellular and molecular levels. Additionally, the integration of AI and machine learning in imaging analysis is refining accuracy and increasing data analysis efficiency, fueled by growing investments and collaborations in the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Preclinical Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Preclinical Imaging Market Segments Analysis

Global Preclinical Imaging Market is segmented by Component, Modality, Application and region. Based on Component, the market is segmented into Hardware Systems and Software & Services. Based on Modality, the market is segmented into Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT), Optical Imaging, Ultrasound Imaging, Single Photon Emission Computed Tomography (SPECT) and Multimodal Imaging. Based on Application, the market is segmented into Drug Discovery & Development, Disease Research, Translational Medicine and Toxicology Studies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Preclinical Imaging Market

The escalating prevalence of chronic diseases, including cancer and neurological disorders, is driving a surge in interest for innovative preclinical imaging techniques that prioritize accuracy and non-invasiveness. This heightened demand is particularly evident among pharmaceutical and biopharmaceutical companies, which utilize these advanced imaging tools to assess drug efficacy, track disease progression, and refine treatment strategies. Additionally, the pressing need for expedited and thorough drug discovery processes is prompting substantial investments in high-resolution and multimodal imaging technologies, further propelling the growth of the global preclinical imaging market as stakeholders seek to enhance research outcomes and therapeutic solutions.

Restraints in the Global Preclinical Imaging Market

The Global Preclinical Imaging market faces significant constraints due to the high costs associated with the acquisition and maintenance of imaging systems. This financial burden can particularly hinder smaller laboratories, startups, and research institutions in developing countries. Advanced imaging technologies, including high-resolution MRI, PET/CT, and hybrid systems, entail not only substantial initial investments but also ongoing expenses for system calibration, software upgrades, maintenance, and consumables. Furthermore, the need to hire or train skilled personnel to operate these sophisticated systems contributes additional operational expenses, posing a considerable challenge in the pursuit of cutting-edge research capabilities.

Market Trends of the Global Preclinical Imaging Market

The Global Preclinical Imaging market is witnessing a significant trend driven by the rising incorporation of artificial intelligence (AI) and machine learning (ML) technologies. These advanced tools are revolutionizing the imaging landscape by facilitating automated image analysis, precise tissue segmentation, and enhanced biomarker identification. As researchers increasingly embrace AI and ML, they benefit from reduced manual workload and improved accuracy, enabling deeper insights from complex imaging data. This trend not only enhances the overall efficiency of preclinical studies but also accelerates the discovery of critical observations, fostering innovation and advancements in biomedical research and drug development.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Preclinical Imaging Market Size by Component & CAGR (2025-2032)

• Market Overview
• Hardware Systems
• Software & Services

Global Preclinical Imaging Market Size by Modality & CAGR (2025-2032)

• Market Overview
• Magnetic Resonance Imaging (MRI)
• Positron Emission Tomography (PET)
• Computed Tomography (CT)
• Optical Imaging
• Ultrasound Imaging
• Single Photon Emission Computed Tomography (SPECT)
• Multimodal Imaging

Global Preclinical Imaging Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery & Development
• Disease Research
• Translational Medicine
• Toxicology Studies

Global Preclinical Imaging Market Size & CAGR (2025-2032)

• North America (Component, Modality, Application)
  • US
  • Canada
• Europe (Component, Modality, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Modality, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Modality, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Modality, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM VisualSonics Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Medical Imaging Systems Ltd. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MR Solutions (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aspect Imaging Limited (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TriFoil Imaging (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MILabs B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric (GE) HealthCare Technologies Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cubresa Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berthold Technologies GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Li-Cor Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sofie (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Molecular Vision (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vieworks Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kub Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medikors Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SCANCO Medical AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations